Peled Amnon has filed 4 insider transactions across 1 company since February 2025.
Most recent transaction: a grant/award of 7576 shares of Silexion Therapeutics Corp ($SLXN) on February 20, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | Silexion Therapeutics Corp | $SLXN | Peled Amnon | Director | A | Ordinary Shares | 7576 | $0.00 | 8,237.0000 | 3,126,642 | 1146.14% | 0.24% |
| Feb. 20, 2026 | Silexion Therapeutics Corp | $SLXN | Peled Amnon | Director | A | Stock Option (right to buy Ordinary Shares) | 8904 | $0.00 | 9,684.0000 | 3,126,642 | 1141.54% | 0.28% |
| Feb. 9, 2025 | Silexion Therapeutics Corp | $SLXN | Peled Amnon | Director | A | Ordinary Shares | 661 | $0.00 | 661.0000 | 8,414,615,000 | 9999.99% | 0.00% |
| Feb. 9, 2025 | Silexion Therapeutics Corp | $SLXN | Peled Amnon | Director | A | Stock Option (right to buy Ordinary Shares) | 780 | $0.00 | 780.0000 | 8,414,615,000 | 9999.99% | 0.00% |